A rational approach towards the borylative ring-opening of vinylepoxides and vinylaziridines, by the in situ formed MeO(-)→bis(pinacolato)diboron adduct, has been developed. The enhanced nucleophilic character of the Bpin (sp(2)) moiety from the reagent favours the SN2' conjugated B addition with the concomitant opening of the epoxide and aziridine rings. The reaction proceeds with total chemoselectivity towards the polyfunctionalised (-OH or -NHTs) allyl boronate. Theoretical calculations have determined the transition states that come from the reaction of the vinylic substrates with the activated MeO(-)→bis(pinacolato)diboron adduct, and a plausible mechanism for the organocatalytic borylative ring opening reaction has been suggested.
A family of arylspiroborates has been prepared by the addition of either 4‐tert‐butylcatechol or 3,5‐di‐tert‐butylcatechol to boric acid and an alkali metal hydroxide. All compounds were characterized fully using multinuclear NMR spectroscopy and by elemental analyses. A single crystal X‐ray diffraction was carried out on potassium (bis‐(3,5‐di‐tertbutyl[1,2‐benzenediolato(2‐)‐O,O′]borate)) (8). All compounds displayed appreciable anti‐microbial activities.
A family of arylspiroborate compounds has been prepared from 2,3-dihydroxynaphthalene and characterized fully using multinuclear NMR spectroscopy and elemental analyses. Single crystal X-ray diffraction studies were carried out on the tetramethylammonium (4) and calcium (6) derivatives. Compound 6 represents the first structurally characterized example of a calcium arylspiroborate salt. All compounds showed modest antifungal and antimycobacterial activities. These results have revealed a new Correspondence to:
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.